Zihuan Wang
Guangzhou, 510515, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
KLF6-driven macrophage-to-myofibroblast transition promotes PD-L1-mediated immune evasion in bladder cancer.
Journal: International immunopharmacology
Published: June 12, 2026
H3K18la-PSMG1 Axis in Bladder Cancer Progression: Curcumin as a Therapeutic Candidate.
Journal: International journal of biological sciences
Published: March 27, 2026
DARS2 Promotes Bladder Cancer Progression by Enhancing PINK1-Mediated Mitophagy.
Journal: International journal of biological sciences
Published: November 26, 2024
MAP4 phosphorylation induced by ARID1A loss sensitizes colorectal cancer cells to EMP.
Journal: Cell death & disease
Published: November 07, 2024
Impact of gut microbiome on radiotherapy and immunotherapy efficacy in microsatellite-stable colorectal cancer: role of propionic acid and B. fragilis.
Journal: British journal of cancer
Published: October 27, 2024
ARID1A loss sensitizes colorectal cancer cells to floxuridine.
Journal: Neoplasia (New York, N.Y.)
Published: August 06, 2024
ARID1A loss enhances sensitivity to c-MET inhibition by dual targeting of GPX4 and iron homeostasis, inducing ferroptosis.
Journal: Cell death and differentiation
Published: July 02, 2024
Adipose-derived stem cells promote glycolysis and peritoneal metastasis via TGF-β1/SMAD3/ANGPTL4 axis in colorectal cancer.
Journal: Cellular and molecular life sciences : CMLS
Published: August 13, 2023
VDR Signaling via the Enzyme NAT2 Inhibits Colorectal Cancer Progression.
Journal: Frontiers in pharmacology
Published: June 19, 2021
PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades.
Journal: Aging
Published: August 26, 2020
Electrolyte disorders are ERAS-associated in patients undergoing hepato-pancreato-biliary surgery.
Journal: Langenbeck's archives of surgery
Published: April 29, 2020
Last Updated: 09/26/2026